Skip to content
Rare Disease Week 2024, taking place February 25–28, is an important annual reminder of the need to find cures and improve therapies for patients. […]
Rare Disease Week 2024: standing up for 1 in 10 Americans Read More »
Agricultural productivity has been failing to meet the targets necessary to feed the world’s growing population, says the latest Global Agricultural Productivity (GAP) report.
Agricultural productivity lags, 2023 GAP report shows Read More »
Before heading home for President’s Day recess, Members of Congress made progress on a few priorities for the biotech industry. Of note, the House
House introduces bill to reauthorize PPRV Read More »
Encouraging farmers to use biotech and other climate tech to make agriculture more sustainable requires ensuring that their impact on climate is measured accurately
USDA forum puts focus on biotech for sustainable farming Read More »
GSK believes that “innovation starts when we stop to listen.” In 2023, GSK took a moment to engage with a variety of people across
GSK survey shows optimism for the future of biotech innovation Read More »
Contention over the Bayh-Dole march-in rights provision is in the news again. The National Institute of Standards and Technology (NIST) proposes using the process
BIO comments on NIST proposal to use march-in rights for price controls Read More »
Breakthroughs in biotech involve collaboration at every level. While entrepreneurial innovation is often the most visible, it’s policymaking and government leadership that lays the
Black History Month: the policymakers & government leaders advancing biotech Read More »
Tuesday, Feb. 6 was a busy day on Capitol Hill for health legislation. Two bills advanced through committees. The House Oversight & Investigations Committee
Legislation on PBM reform, preventive care advances in House Read More »
A bipartisan amendment to the Inflation Reduction Act (IRA), introduced in the House on January 31, would fix the law’s small molecule “pill penalty”
EPIC Act would fix IRA’s ‘pill penalty’ for small molecule drugs Read More »
On January 31, the House passed legislation to restore the immediate expensing of R&D expenses. The Biotechnology Innovation Organization (BIO) has long advocated for
House passes bill restoring full R&D expensing Read More »
